Inhibitory effects on L- and N-type calcium channels by a novel CaVβ1 variant identified in a patient with autism spectrum disorder

Naunyn Schmiedebergs Arch Pharmacol. 2022 Apr;395(4):459-470. doi: 10.1007/s00210-022-02213-7. Epub 2022 Feb 5.

Abstract

Voltage-gated calcium channel (VGCC) subunits have been genetically associated with autism spectrum disorders (ASD). The properties of the pore-forming VGCC subunit are modulated by auxiliary β-subunits, which exist in four isoforms (CaVβ1-4). Our previous findings suggested that activation of L-type VGCCs is a common feature of CaVβ2 subunit mutations found in ASD patients. In the current study, we functionally characterized a novel CaVβ1b variant (p.R296C) identified in an ASD patient. We used whole-cell and single-channel patch clamp to study the effect of CaVβ1b_R296C on the function of L- and N-type VGCCs. Furthermore, we used co-immunoprecipitation followed by Western blot to evaluate the interaction of the CaVβ1b-subunits with the RGK-protein Gem. Our data obtained at both, whole-cell and single-channel levels, show that compared to a wild-type CaVβ1b, the CaVβ1b_R296C variant inhibits L- and N-type VGCCs. Interaction with and modulation by the RGK-protein Gem seems to be intact. Our findings indicate functional effects of the CaVβ1b_R296C variant differing from that attributed to CaVβ2 variants found in ASD patients. Further studies have to detail the effects on different VGCC subtypes and on VGCC expression.

Keywords: Autism spectrum disorder; CACNB1 protein; Calcium channels; Patch clamp technique.

Publication types

  • Case Reports

MeSH terms

  • Autism Spectrum Disorder* / genetics
  • Calcium Channels, L-Type* / genetics
  • Calcium Channels, L-Type* / metabolism
  • Calcium Channels, N-Type* / genetics
  • Calcium Channels, N-Type* / metabolism
  • Humans

Substances

  • Calcium Channels, L-Type
  • Calcium Channels, N-Type